BIOMAT Database Logo BIOMAT Database Logo

A trial of cromoglycic acid in recurrent aphthous ulceration. 1975

A E Dolby, and D M Walker

In a random double blind trial with crossover on 24 patients with recurrent aphthous ulcers (RAU) cromoglycic acid tablets significantly reduced the pain experienced when compared with placebo but did not reduce the number of days with oral ulceration present. Of the 15 patients completing the trial, 12 preferred CGA to placebo, two preferred the placebo and one had no preference. It is concluded that the cromoglycate compounds may have a valuable part to play in the symptomatic relief of RAU.

UI MeSH Term Description Entries
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002130 Calcium Phosphates Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements. Phosphates, Calcium
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013281 Stomatitis, Aphthous A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742) Aphthae,Canker Sore,Periadenitis Mucosa Necrotica Recurrens,Ulcer, Aphthous,Aphthous Stomatitides,Aphthous Stomatitis,Aphthous Ulcer,Aphthous Ulcers,Canker Sores,Sore, Canker,Sores, Canker,Stomatitides, Aphthous,Ulcers, Aphthous
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

A E Dolby, and D M Walker
A clinical trial of prostaglandin E2 in recurrent aphthous ulceration.
August 1993, British dental journal,
A E Dolby, and D M Walker
Double-blind trial of tetracycline in recurrent aphthous ulceration.
January 1978, Journal of oral pathology,
A E Dolby, and D M Walker
Double blind crossover trial of levamisole in recurrent aphthous ulceration.
October 1976, Lancet (London, England),
A E Dolby, and D M Walker
Management of recurrent aphthous ulceration. A trial of chlorhexidine gluconate gel.
August 1976, British dental journal,
A E Dolby, and D M Walker
Recurrent aphthous ulceration in children--a review.
April 1992, International journal of paediatric dentistry,
A E Dolby, and D M Walker
Clinical trial of Sporlac in the treatment of recurrent aphthous ulceration.
January 1980, The Uttar Pradesh State dental journal : an official publication of the State U.P. Dental Branch of the Indian Dental Association,
A E Dolby, and D M Walker
RECURRENT APHTHOUS ULCERATION AND AUTOIMMUNITY.
November 1964, Lancet (London, England),
A E Dolby, and D M Walker
Recurrent aphthous ulceration--an update.
January 1985, Journal (Indiana Dental Association),
A E Dolby, and D M Walker
Transient benefits for topical hyaluronic acid in recurrent aphthous ulceration.
January 2007, Evidence-based dentistry,
A E Dolby, and D M Walker
Natural immunity in recurrent aphthous ulceration.
May 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
Copied contents to your clipboard!